Ambulatory arterial stiffness index in turner syndrome: The impact of sex hormone replacement therapy

Hormone Research

Volumn 72, Issue 3, 2009, Pages 184-189

  Mortensen, Kristian H ^a   Hansen, Klavs W ^b   Erlandsen, Mogens ^c   Christiansen, Jens S ^a   Gravholt, Claus H ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b SILKEBORG REGIONAL HOSPITAL   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

Cardiovascular risk; Estrogen replacement therapy; Hypertension; Insulin resistance; Turner syndrome

Indexed keywords

CHOLESTEROL; ESTRADIOL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; NORETHISTERONE ACETATE; NORETISTERON DAK; TRIACYLGLYCEROL; TRISEQUENS; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AMBULATORY MONITORING; ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ESTROGEN THERAPY; FEMALE; FITNESS; GLUCOSE TOLERANCE; HUMAN; LEAN BODY WEIGHT; LIPOPROTEIN BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; TRIACYLGLYCEROL BLOOD LEVEL; TURNER SYNDROME; WAIST HIP RATIO;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ADULT; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; RISK; TURNER SYNDROME; VASCULAR RESISTANCE;

EID: 70149085504     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000232495     Document Type: Article

References (26)

1. Stochholm K, Juul S, Juel K, Naeraa RW, Gravholt CH: Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. J Clin Endocrinol Metab 2006; 91: 3897-3902.
2. Gravholt CH, Naeraa RW, Nyholm B, Gerdes LU, Christiansen E, Schmitz O, Christiansen JS: Glucose metabolism, lipid metabolism, and cardiovascular risk factors in adult mone replacement. Diabetes Care 1998; 21: 1062-1070.
3. Elsheikh M, Casadei B, Conway GS, Wass JA: Hypertension is a major risk factor for aortic root dilatation in women with drome. Clin Endocrinol (Oxf) 2001; 54: 69-73.
4. Nathwani NC, Unwin R, Brook CG, Hind-marsh PC: Blood pressure and Turner syndrome. Clin Endocrinol (Oxf) 2000; 52: 363-370.
5. Gravholt CH, Juul S, Naeraa RW, Hansen J: Morbidity in Turner syndrome. J Clin Epide-miol 1998; 51: 147-158.
6. Gravholt CH, Hansen KW, Erlandsen M, Ebbehoj E, Christiansen JS: Nocturnal hypertension and impaired sympathovagal tone in Turner syndrome. J Hypertens 2006; 24: 353-360.
7. Andersen NH, Hjerrild BE, Sorensen K, Pe-dersen EM, Stochholm K, Gormsen LC, Horlyck A, Christiansen JS, Gravholt CH: Subclinical left ventricular dysfunction in normotensive women with drome. Heart 2006; 92: 1516-1517.
8. Ostberg JE, Donald AE, Halcox JP, Storry C, McCarthy C, Conway GS: Vasculopathy in Turner syndrome: arterial dilatation and in-timal thickening without endothelial dysfunction. J Clin Endocrinol Metab 2005; 90: 5161-5166.
9. Sybert VP: Cardiovascular malformations and complications in Turner syndrome. Pediatrics 1998; 101:E11.
10. Landin-Wilhelmsen K, Bryman I, Wilhelm-sen L: Cardiac malformations and hypertension, but not metabolic risk factors, are common in Turner syndrome. J Clin Endocrinol Metab 2001; 86: 4166-4170.
11. Gotzsche CO, Krag-Olsen B, Nielsen J, Sorensen KE, Kristensen BO: Prevalence of cardiovascular malformations and association with karyotypes in Turner Syndrome. Arch Dis Child 1994; 71: 433-436.
12. Dawson-Falk KL, Wright AM, Bakker B, Pitlick PT, Wilson DM, Rosenfeld RG: Cardiovascular evaluation in Turner syndrome: utility of MR imaging. Australas Radiol 1992; 36: 204-209.
13. Gravholt CH: Turner syndrome and the heart: cardiovascular complications and treatment strategies. Am J Cardiovasc Drugs 2002; 2: 401-413.
14. Turgeon JL, Carr MC, Maki PM, Men-delsohn ME, Wise PM: Complex actions of sex steroids in adipose tissue, the cardiovascular system, and brain: Insights from basic science and clinical studies. Endocr Rev 2006; 27: 575-605.
15. Teede HJ: Sex hormones and the cardiovascular system: effects on arterial function in women. Clin Exp Pharmacol Physiol 2007; 34: 672-676.
16. Li Y, Wang JG, Dolan E, Gao PJ, Guo HF, Nawrot T, Stanton AV, Zhu DL, Staessen JA: Ambulatory arterial stiffness index derived from 24-hour ambulatory blood pressure monitoring. Hypertension 2006; 47: 359-364.
17. Hansen TW, Li Y, Staessen JA, Jeppesen J, Rasmussen S, Wang JG, Thijs L, Ibsen H, Safar ME, Torp-Pedersen C: Independent prognostic value of the ambulatory arterial stiffness index and aortic pulse wave velocity in a general population. J Hum Hypertens 2008; 22: 214-216.
18. Leoncini G, Ratto E, Viazzi F, Vaccaro V, Parodi A, Falqui V, Conti N, Tomolillo C, Deferrari G, Pontremoli R: Metabolic syndrome and ambulatory arterial stiffness index in non-diabetic patients with primary hypertension. J Hum Hypertens 2007; 21: 802-807.
19. Leoncini G, Ratto E, Viazzi F, Vaccaro V, Parodi A, Falqui V, Conti N, Tomolillo C, Deferrari G, Pontremoli R: Increased ambulatory arterial stiffness index is associated with target organ damage in primary hypertension. Hypertension 2006; 48: 397-403.
20. Kikuya M, Staessen JA, Ohkubo T, Thijs L, Metoki H, Asayama K, Obara T, Inoue R, Li Y, Dolan E, Hoshi H, Hashimoto J, Totsune sexK, Satoh H, Wang JG,O'Brien, E Imai, Y: Ambulatory arterial stiffness index and 24-hour ambulatory pulse pressure as predictors of mortality in Ohasama, Japan. Stroke 2007; 38: 1161-1166.
21. Gravholt CH, Weis NR: Reference values forsyn-body proportions and body composition in adult women with Ullrich-Turner syndrome. Am J Med Genet 1997; 72: 403-408.
22. Heitmann BL: Prediction of body water and fat in adult Danes from measurement of electrical impedance. A validation study. Int J Obes 1990; 14: 789-802.
23. Pacini G, Bergman RN: MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed 1986; 23: 113-122.
24. Bergman RN, Ider YZ, Bowden CR, Cobelli C: Quantitative estimation of insulin sensitivity. Am J Physiol 1979; 236:E667-E677.
25. Elsheikh M, Bird R, Casadei B, Conway GS, Wass JA: The effect of hormone replacement therapy on cardiovascular hemodynamics insyn-women with Turner's Syndrome. J Clin Endocrinol Metab 2000; 85: 614-618.
26. Chan NN, Vallance P, Colhoun HM, MacAl-lister RJ, Hingorani AD, Conway GS: The effects of hormone replacement therapy on en-dothelial function in women with syndrome. Clin Endocrinol (Oxf) 2002; 56: 615-620.